DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

References

Bidard FC, Callens C, Dalenc F. et al.
Prognostic impact of ESR1 mutations in ER+ HER2- MBC patients prior treated with first line AI and palbociclib: An exploratory analysis of the PADA-1 trial.

J Clin Oncol 2020;
38 (no. 15_suppl): 1010
doi:10.1200/JCO.2020.38.15_suppl.1010

Download Bibliographical Data

Search in: